Hims & Hers Stock Drops 12.8% After Short Report [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
Shares recovered slightly during trading and are down 7.8% at 2:30 p.m. ET today. The short-seller's report Hunterbrook Media put out what appears to be a journalistic article, but it's in fact tied to Hunterbrook Capital, which is short the stock. As with any short report, investors should read it with an open mind but remain skeptical of the motivations of the writers. In this case, Hunterbrook criticized Hims & Hers' GLP-1 weight-loss treatment, which is a compound made by a pharmacy and temporarily approved to fill shortages of GLP-1 drugs, and not a government-approved medication itself. There are questions, even by the Food and Drug Administration, about how effective the treatment is compared to approved versions of GLP-1. The Hunterbrook report also criticized the company's prescription process and insider sales of the stock. Risks at Hims & Hers It isn't that the short-seller's report is incorrect, it's that it was presented in a way that only told one side of the
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- HIMS Stock Tumbles: Here's Why It's a Buy Right Now [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Jefferies Financial Group Inc. from $14.00 to $23.00. They now have a "hold" rating on the stock.MarketBeat
- The War Over Cheaper Ozempic Won't End Well for Some Investors [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Health, Inc. (HIMS) Flat As Market Sinks: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Alcon (ALC) Achieves FDA 510(k) Clearance for Unity VCS and Unity CS [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 5/6/24 - Beat
HIMS
Sec Filings
- 6/25/24 - Form 4
- 6/25/24 - Form 4
- 6/25/24 - Form 4
- HIMS's page on the SEC website